Relationship between heart rate variability, blood pressure and arterial wall properties during air and oxygen breathing in healthy subjects

Autonomic Neuroscience: Basic and Clinical

Volumn 178, Issue 1-2, 2013, Pages 60-66

  Graff, Beata ^a   Szyndler, Anna ^a   Czechowicz, Krzysztof ^a   Kucharska, Wiesława ^a   Graff, Grzegorz ^b   Boutouyrie, Pierre ^c   Laurent, Stephane ^c   Narkiewicz, Krzysztof ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b GDANSK UNIVERSITY OF TECHNOLOGY   (Poland)

^c PARIS CARDIOVASCULAR RESEARCH CENTER   (France)

Author keywords

Autonomic nervous system; Heart rate variability; Hyperoxia

Indexed keywords

ADULT; ARTERIAL WALL THICKNESS; ARTERY DIAMETER; ARTERY DILATATION; ARTICLE; BLOOD PRESSURE VARIABILITY; BREATHING RATE; COMMON CAROTID ARTERY; FEMALE; HEART HEMODYNAMICS; HEART RATE VARIABILITY; HUMAN; HUMAN EXPERIMENT; HYPEROXIA; IMPEDANCE CARDIOGRAPHY; MALE; NORMAL HUMAN; OXYGEN BREATHING; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL;

AUTONOMIC NERVOUS SYSTEM; HEART RATE VARIABILITY; HYPEROXIA;

ADULT; BAROREFLEX; BLOOD PRESSURE; CARDIOGRAPHY, IMPEDANCE; CAROTID ARTERIES; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; OXYGEN; REGRESSION ANALYSIS; RESPIRATION; STATISTICS, NONPARAMETRIC; TIME FACTORS;

EID: 84885179611     PISSN: 15660702     EISSN: 18727484     Source Type: Journal    
DOI: 10.1016/j.autneu.2013.04.009     Document Type: Article

References (38)

1. Anderson K.J., Harten J.M., Booth M.G., Berry C., McConnachie A., Rankin A.C., Kinsella J. The cardiovascular effects of normobaric hyperoxia in patients with heart rate fixed by permanent pacemaker. Anaesthesia 2010, 65:167-171.
2. Bak Z., Sjöberg F., Rousseau A., Steinvall I., Janerot-Sjoberg B. Human cardiovascular dose-response to supplemental oxygen. Acta Physiol. (Oxf.) 2007, 191:15-24.
3. Becker H.F., Polo O., McNamara S.G., Berthon-Jones M., Sullivan C.E. Effect of different levels of hyperoxia on breathing in healthy subjects. J. Appl. Physiol. 1996, 81:1683-1690.
4. Bernstein D.P. Continuous noninvasive real-time monitoring of stroke volume and cardiac output by thoracic electrical bioimpedance. Crit. Care Med. 1986, 14:898-901.
5. Crawford P., Good P.A., Gutierrez E., Feinberg J.H., Boehmer J.P., Silber D.H., Sinoway L.I. Effects of supplemental oxygen on forearm vasodilation in humans. J. Appl. Physiol. 1997, 82:1601-1606.
6. Daly W.J., Bondurant S. Effects of oxygen breathing on the heart rate, blood pressure, and cardiac index of normal men-resting, with reactive hyperemia, and after atropine. J. Clin. Invest. 1962, 41:126-132.
7. Ganz P., Vita J.A. Testing endothelial vasomotor function: nitric oxide, a multipotent molecule. Circulation 2003, 108:2049-2053.
8. Gole Y., Gargne O., Coulange M., Steinberg J.G., Bouhaddi M., Jammes Y., Regnard J., Boussuges A. Hyperoxia-induced alterations in cardiovascular function and autonomic control during return to normoxic breathing. Eur. J. Appl. Physiol. 2011, 111:937-946.
9. Guyton A.C., Hall J.E. Textbook of Medical Physiology 2006, 211-212. Elsevier Saunders, Philadelphia.
10. Haque W.A., Boehmer J., Clemson B.S., Leuenberger U.A., Silber D.H., Sinoway L.I. Hemodynamic effects of supplemental oxygen administration in congestive heart failure. J. Am. Coll. Cardiol. 1996, 27:353-357.
11. Hardy J.C., Gray K., Whisler S., Leuenberger U. Sympathetic and blood pressure responses to voluntary apnea are augmented by hypoxemia. J. Appl. Physiol. 1994, 77:2360-2365.
12. Hering D., Zdrojewski Z., Król E., Kara T., Kucharska W., Somers V.K., Rutkowski B., Narkiewicz K. Tonic chemoreflex activation contributes to the elevated muscle sympathetic nerve activity in patients with chronic renal failure. J. Hypertens. 2007, 25:157-161.
13. Izdebska E., Izdebski J., Cybulska I., Makowiecka-Ciesla M., Trzebski A. Moderate exercise training reduces arterial chemoreceptor reflex drive in mild hypertension. J Physiol Pharmacol. Suppl 2006, 11(57):93-102.
14. Kara T., Narkiewicz K., Somers V.K. Chemoreflexes-physiology and clinical implications. Acta Physiol. Scand. 2003, 177:377-384. (Mar.).
15. Kuvin J.T., Patel A.R., Sliney K.A., Pandian N.G., Sheffy J., Schnall R.P., Karas R.H., Udelson J.E. Assessment of peripheral vascular endothelial function with finger arterial pulse wave amplitude. Am. Heart J. 2003, 146:168-174.
16. La Rovere M., Pinna G., Raczak G. Baroreflex sensitivity: measurement and clinical implications. Ann. Noninvasive Electrocardiol. 2008, 13:191-207.
17. 2. J. Appl. Physiol. 1962, 17:417-420.
18. Lund V.E., Kentala E., Scheinin H., Klossner J., Helenius H., Sariola-Heinonen K., Jalonen J. Heart rate variability in healthy volunteers during normobaric and hyperbaric hyperoxia. Acta Physiol. Scand. 1999, 167:29-35.
19. Mak S., Egri Z., Tanna G., Colman R., Newton G.E. Vitamin C prevents hyperoxia-mediated vasoconstriction and impairment of endothelium-dependent vasodilation. Am. J. Physiol. Heart Circ. Physiol. 2002, 282:H2414-H2421.
20. Meinders J.M., Brands P.J., Willigers J.M., Kornet L., Hoeks A.P.G. Assessment of the spatial homogeneity of artery dimension parameters with high frame rate 2-D B-mode. Ultrasound Med. Biol. 2001, 27:785-794.
21. Moradkhan R., Sinoway L.I. Revisiting the role of oxygen therapy in cardiac patients. J. Am. Coll. Cardiol. 2010, 56:1013-1016.
22. Narkiewicz K., van de Borne P.J., Montano N., Dyken M.E., Phillips B.G., Somers V.K. Contribution of tonic chemoreflex activation to sympathetic activity and blood pressure in patients with obstructive sleep apnea. Circulation 1998, 97:943-945.
23. Nattie E. Why do we have both peripheral and central chemoreceptors?. J. Appl. Physiol. 2006, 100:9-10.
24. Nohria A., Gerhard-Herman M., Creager M.A., Hurley S., Mitra D., Ganz P. Role of nitric oxide in the regulation of digital pulse volume amplitude in humans. J. Appl. Physiol. 2006, 101:545-548.
25. Parati G., Di Rienzo M., Mancia G. How to measure baroreflex sensitivity: from the cardiovascular laboratory to daily life. J. Hypertens. 2000, 18:7-19.
26. Park J.H., Balmain S., Berry C., Morton J.J., McMurray J.J. Potentially detrimental cardiovascular effects of oxygen in patients with chronic left ventricular systolic dysfunction. Heart 2010, 96:533-538.
27. Querido J.S., Kennedy P.M., Sheel A.W. Hyperoxia attenuates muscle sympathetic nerve activity following isocapnic hypoxia in humans. J. Appl. Physiol. 2010, 108:906-912.
28. Rawles J.M., Kenmure A.C. Controlled trial of oxygen in uncomplicated myocardial infarction. Br. Med. J. 1976, 8:1121-1123.
29. Rousseau A., Tesselaar E., Henricson J., Sjöberg F. Prostaglandins and radical oxygen species are involved in microvascular effects of hyperoxia. J. Vasc. Res. 2010, 47:441-450.
30. Rubanyi G.M., Vanhoutte P.M. Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am. J. Physiol. 1986, 250:H822-H827.
31. Rubinshtein R., Kuvin J.T., Soffler M., Lennon R.J., Nelson R.E., Pumper G.M., Lerman L.O. Assessment of endothelial function by peripheral arterial tonometry predicts cardiovascular events beyond the Framingham risk score. Eur. Heart J. 2010, 31:1142-1148.
32. Seals D.R., Johnson D.G., Fregosi R.F. Hyperoxia lowers sympathetic activity at rest but not during exercise in humans. Am. J. Physiol. 1991, 260:R873-R878.
33. Siński M., Lewandowski J., Przybylski J., Bidiuk J., Abramczyk P., Ciarka A., Gaciong Z. Tonic activity of carotid body chemoreceptors contributes to the increased sympathetic drive in essential hypertension. Hypertens. Res. 2012, 35:487-491.
34. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 1996, 93:1043-1065.
35. Thomson A.J., Drummond G.B., Waring W.S., Webb D.J., Maxwell S.R. Effects of short-term isocapnic hyperoxia and hypoxia on cardiovascular function. J. Appl. Physiol. 2006, 101:809-816.
36. van de Borne P., Oren R., Anderson E.A., Mark A.L., Somers V.K. Tonic chemoreflex activation does not contribute to elevated muscle sympathetic nerve activity in heart failure. Circulation 1996, 15:1325-1328.
37. Waring W.S., Thomson A.J., Adwani S.H., Rosseel A.J., Potter J.F., Webb D.J., Maxwell S.R. Cardiovascular effects of acute oxygen administration in healthy adults. J. Cardiovasc. Pharmacol. 2003, 42:245-250.
38. Wijesinghe M., Perrin K., Ranchord A., Simmonds M., Weatherall M., Beasley R. Routine use of oxygen in the treatment of myocardial infarction: systematic review. Heart 2009, 95:198-202.